116 related articles for article (PubMed ID: 38653591)
1. Prognostic significance of lymph node count in surgically treated patients with T
Assad A; Barletta F; Incesu RB; Scheipner L; Morra S; Baudo A; Garcia CC; Tian Z; Ahyai S; Longo N; Chun FKH; Shariat SF; Tilki D; Briganti A; Saad F; Karakiewicz PI
Urol Oncol; 2024 Aug; 42(8):248.e1-248.e9. PubMed ID: 38653591
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Scheipner L; Barletta F; Cano Garcia C; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; Pichler M; Ahyai S; Karakiewicz PI
Ann Surg Oncol; 2023 Dec; 30(13):8780-8785. PubMed ID: 37815682
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.
Barletta F; Tappero S; Morra S; Incesu RB; Cano Garcia C; Piccinelli ML; Scheipner L; Baudo A; Tian Z; Gandaglia G; Stabile A; Mazzone E; Terrone C; Longo N; Tilki D; Chun FKH; de Cobelli O; Ahyai S; Carmignani L; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2023 Dec; 21(6):e461-e466.e1. PubMed ID: 37365054
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy.
Liu YL; Xu HT; Jiang SX; Yang YM; Cui BB
J Surg Oncol; 2014 Mar; 109(3):234-8. PubMed ID: 24449194
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical Carcinoma: The Value of Lymphadenectomy.
Tseng J; DiPeri T; Chen Y; Shouhed D; Ben-Shlomo A; Burch M; Phillips E; Jain M
Ann Surg Oncol; 2022 Mar; 29(3):1965-1970. PubMed ID: 34792698
[TBL] [Abstract][Full Text] [Related]
6. Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.
Nilubol N; Patel D; Kebebew E
World J Surg; 2016 Mar; 40(3):697-705. PubMed ID: 26510563
[TBL] [Abstract][Full Text] [Related]
7. Lymph node count impacts survival following post-chemotherapy retroperitoneal lymphadenectomy for non-seminomatous testicular cancer: a population-based analysis.
Bhanvadia RR; Rodriguez J; Bagrodia A; Eggener SE
BJU Int; 2019 Nov; 124(5):792-800. PubMed ID: 31054211
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
9. Positive Lymph Nodes in Adrenocortical Carcinoma: What Does It Mean?
Sada A; Glasgow AE; Lyden ML; Thompson GB; Dy BM; McKenzie TJ; Habermann EB
World J Surg; 2021 Jan; 45(1):188-194. PubMed ID: 33034710
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.
Panjwani S; Moore MD; Gray KD; Finnerty BM; Beninato T; Brunaud L; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2017 Nov; 24(12):3617-3623. PubMed ID: 28895102
[TBL] [Abstract][Full Text] [Related]
11. Critical analysis of lymph node examination in patients undergoing curative-intent resection for adrenocortical carcinoma.
Deschner BW; Stiles ZE; DeLozier OM; Drake JA; Tsao M; Glazer ES; Deneve JL; Yakoub D; Dickson PV
J Surg Oncol; 2020 Nov; 122(6):1152-1162. PubMed ID: 32705677
[TBL] [Abstract][Full Text] [Related]
12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
13. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
[TBL] [Abstract][Full Text] [Related]
14. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Prognostic Value of Lymph Node Dissection in Treating Adrenocortical Carcinoma: A National Experience.
Alanee S; Dynda D; Holland B
Anticancer Res; 2015 Oct; 35(10):5575-9. PubMed ID: 26408728
[TBL] [Abstract][Full Text] [Related]
17. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
[No Abstract] [Full Text] [Related]
18. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
Gerry JM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Wang TS; Glenn JA; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Hatzaras I; Shenoy R; Pawlik TM; Norton JA; Poultsides GA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):708-713. PubMed ID: 27590329
[TBL] [Abstract][Full Text] [Related]
20. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
Honselmann KC; Pergolini I; Castillo CF; Deshpande V; Ting D; Taylor MS; Bolm L; Qadan M; Wellner U; Sandini M; Bausch D; Warshaw AL; Lillemoe KD; Keck T; Ferrone CR
Ann Surg; 2020 Aug; 272(2):357-365. PubMed ID: 32675550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
